Drugs / BMS-903452
last change Jan 2012 re-read 3 minutes ago

BMS-903452

Small molecule

Developed for
diabetes mellitus
Investigated by
Bristol-Myers Squibb

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01240980 Nov 2010 → Jan 2012 diabetes mellitus Bristol-Myers Squibb Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as BMS-903452 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01240980 ↗
Modality Small molecule — CHEMBL3338194 ↗